Talc Lawsuit Updates
Stay informed about the latest developments in talc powder litigation — court rulings, settlement news, scientific research, and what it all means for your case.
For informational purposes only. This page provides general updates about talc litigation and does not constitute legal advice. Contact us directly for guidance specific to your situation.
Third Circuit Rejects J&J Bankruptcy Strategy for Third Time
The U.S. Court of Appeals for the Third Circuit has once again rejected Johnson & Johnson's attempt to use a subsidiary bankruptcy — dubbed the "Texas Two-Step" — to limit its liability in talc litigation. The court found that the LTL Management subsidiary was not in genuine financial distress and that the bankruptcy filing was being used in bad faith to avoid litigation. This ruling means that individual talc lawsuits can continue to move forward through the courts, and plaintiffs retain their right to pursue full compensation through the traditional legal process.
Settlement Discussions Resume in MDL; New Offer Framework Proposed
Attorneys representing plaintiffs in MDL No. 2738 in the U.S. District Court for the District of New Jersey have reported that settlement discussions with defendants have resumed following the bankruptcy ruling. A new framework for evaluating and categorizing claims has been proposed, which could accelerate the resolution of thousands of pending cases. While no global settlement has been reached, legal observers note that the failed bankruptcy strategy has increased pressure on defendants to negotiate in good faith.
New Epidemiological Study Confirms Link Between Talc and Ovarian Cancer
A large-scale epidemiological study published in a peer-reviewed medical journal in January 2025 adds to the substantial body of scientific evidence connecting regular genital application of talc-based products to an elevated risk of ovarian cancer. The study analyzed data from more than 250,000 women over a 15-year period and found a statistically significant association between talc use and ovarian cancer incidence. This research is expected to play a significant role in supporting plaintiffs' claims in ongoing and future litigation.
$110.5 Million Jury Verdict Entered in 2024 Talc Trial
A jury in a 2024 talc trial entered a verdict of $110.5 million in favor of the plaintiff, who alleged that long-term use of Johnson & Johnson Baby Powder caused her ovarian cancer. The verdict included both compensatory and punitive damages. This case is notable for its size and for coming years into the litigation, demonstrating that juries continue to find in favor of plaintiffs who can establish a strong connection between their talc use and cancer diagnosis. The defendant has indicated it will appeal.
Case Management Order Sets Bellwether Trial Schedule for 2025
The presiding judge in MDL No. 2738 has issued a case management order establishing a schedule for bellwether trials in 2025. Bellwether trials are selected cases that go to trial first, serving as test cases that help both sides assess the strength of their arguments. The outcomes of these trials often influence settlement negotiations for the remaining thousands of cases in the MDL. Attorneys on both sides are expected to use the next several months to finalize expert witness lists and prepare trial strategies.
FDA Finalizes Rule Banning Talc in Cosmetics
The U.S. Food and Drug Administration (FDA) finalized a rule in late 2024 banning the use of talc in cosmetic products sold in the United States. The rule, which takes effect in 2025, marks a significant regulatory milestone in the decades-long debate over the safety of talc-based products. While the rule does not directly affect pending litigation, it is seen as an acknowledgment by federal regulators of the potential health risks associated with talc — a development that plaintiffs' attorneys say supports their legal claims.
Plaintiff Attorneys File Motion to Consolidate New State Court Cases
In addition to the federal MDL, thousands of talc cases are being litigated in state courts across the country. Plaintiffs' attorneys have filed a motion in several states to consolidate these cases for efficiency. Coordination between state and federal proceedings is a complex but important aspect of managing one of the largest product liability litigations in U.S. history. Attorneys note that state court cases may proceed on a different timeline from the federal MDL and may offer distinct advantages for certain plaintiffs.
More Updates Coming
Talc litigation is an active and rapidly evolving area. We update this page regularly as new developments emerge. For the most current information about your specific case, contact our legal team directly.
Contact Our TeamWhat These Updates Mean for You
Here is the bottom line on the current state of talc litigation.
Cases Are Still Moving Forward
Despite J&J's bankruptcy attempts, courts have ruled that talc lawsuits can proceed. If you have a qualifying claim, the legal path to compensation remains open.
New Cases Are Still Being Filed
Thousands of new talc claims continue to be filed each year. It is not too late to pursue your case, but statutes of limitations do apply.
Science Supports Plaintiffs
Mounting scientific evidence linking talc to ovarian cancer strengthens the position of plaintiffs in ongoing and future litigation.
Settlements Remain Possible
With the bankruptcy strategy rejected, defendants face increasing pressure to negotiate fair settlements. Many cases continue to resolve through settlement.
Regulatory Recognition of Risk
The FDA's ban on talc in cosmetics is a significant acknowledgment of the health risks — evidence that supports claims already in litigation.
Act Promptly
Filing deadlines vary by state and are strictly enforced. The sooner you reach out, the more options you may have available to you.
Get Up-to-Date Guidance on Your Case
The legal landscape is changing. Make sure you have the latest information and understand your rights. Contact us for a free consultation.